Log In
Free Trial
Looking for inspirations for innovation challenges? Try Patsnap Eureka!
Learn More
I-MAB Biopharma Co., Ltd.
Public Company
Follow
View Corporate Tree
Create Alert
Overview
Patent
Funding
Investment
Acquisition
Member
Expert
Financial
News
Basic Info
Headquarter
Asia, China
Founded Year
2016
Stock Symbol
NASDAQ: IMAB
Social Media
http://www.i-mabbiopharma.com
I-Mab is a company that provides Medicine, Biomedicine, Cancer and more. I-Mab is headquartered in China Asia. I-Mab was founded in 2016. I-Mab has a total of 52 patents and 1 literature
Related Topics
Medicine
Biomedicine
Cancer
Biopharmaceutical
Biotechnology
Exosome
Biophysics
Clinical trial
Dementia
Pharmaceutics
Aptamer
Drug design
Cancer research
Toxicology
Clinical research
Biobank
Microarray
Drug marketing
Contract research organization
Cell signaling
Login to view all basic info
Data Snapshot
52
Patent
1
Literature
USD 13.65 M
Revenue
162
News
Innovation Word Cloud
Analysis include all subsidiaries
A quick overview of tech portfolio with the top keywords and phrases extracted from patents of I-Mab
Overall
Recent 3 years
Download
High Related Markets
Mentioned companies in the market reports of major market categories and sectors by I-Mab
Market Category
Pharmaceuticals
Healthcare
Market Segment
-
Diagnostics
Related Company
Eli Lilly & Co.
Gilead Sciences, Inc.
[+n]
QIAGEN NV
Klaria Pharma Holding AB
[+n]
Related Market Sectors
Big Pharma Partnering Terms and Agreements
Clinical Stage Partnering Terms and Agreements
Coronavirus Disease
[+n]
Co-development Partnering Terms and Agreements
Manufacturing and Supply Partnering Terms and Agreements
Option and Evaluation Partnership Terms and Agreements
Download
Innovation Matrix
Analysis include all subsidiaries
visualizing technology portfolio of hot application areas and blank areas for I-Mab
All Patents
Active Patents
Inactive Patents
Pending Patents
Time Range:
Overall
Overall
1 year
3 year
5 year
Application Domain L2
Application Domain L2
Application Domain L3
Application Domain L4
High-Tech Industry L1
High-Tech Industry L2
Tech Topic L2
Tech Topic L3
Timeline
Tech Topic L2
Tech Topic L2
Tech Topic L3
High-Tech Industry L1
High-Tech Industry L2
Application Domain L2
Application Domain L3
Application Domain L4
Download
Subsidiary Lists
Subsidiaries with patent applications for I-Mab
Company
I-Mab Biopharma US Ltd.
US MD
STARTUP
I-Mab Biopharma (Shanghai) Co., Ltd.
China Shanghai
I-Mab Biopharma Hong Kong Ltd.
HK undefined
Topics
Antibody
Coronavirus disease 2019 (COVID-19)
Drug
Oncology drugs
Type I hypersensitivity
Blinatumomab
Antibody-drug conjugate
Cancer immunotherapy
Pharmaceutical manufacturing
Immunotherapy
Monoclonal antibody
Clinical trial
[+9]
Medicine
Patents
210
84
1
View More
Download
I-Mab Frequently Asked Questions
What is I-Mab's industry?
I-Mab
is in the industry of:
Pharmaceutical and Medicine Manufacturing
Drugs and Druggists' Sundries Merchant Wholesalers
What technical fields has I-Mab researched?
I-Mab
has researched the technical fields related to
Medicine
Biomedicine
Cancer
Biopharmaceutical
Biotechnology
Exosome
Biophysics
Clinical trial
Dementia
Pharmaceutics
Aptamer
Drug design
Cancer research
Toxicology
Clinical research
Biobank
Microarray
Drug marketing
Contract research organization
Cell signaling
What is I-Mab's total number of patents?
I-Mab
has
52
patents in total.
What is I-Mab's market cap?
I-Mab
is currently worth
$ 3.79 B
.
What kind of company is I-Mab?
Develops and manufactures medicines for cancer and autoimmune diseases...
What is I-Mab's official website?
I-Mab
's official website is
http://www.i-mabbiopharma.com
.
What is I-Mab's stock symbol?
I-Mab
's stock symbol is
IMAB
.
Where is I-Mab's headquarters?
I-Mab
is located in Asia, China.
What is I-Mab's NAICS code?
I-Mab
's NAICS:
NASDAQ
.
How many offices does I-Mab have?
I-Mab
has
3
offices.
Where are I-Mab offices?
I-Mab
has offices in
MD,US; Shanghai,China; HK
and in
3
other locations.
Who are I-Mab key executives?
I-Mab
's key executives are
Jing Wu Zang, Huaqiong Shen and Yi Fei Zhu.
Who are I-Mab competitors?
Competitors of
I-Mab
include
Eli Lilly & Co
Gilead Sciences
and
Inovio Pharmaceuticals
.
Show all question
Related Companies
Venus Medtech (Hangzhou), Inc.
Zhejiang, China
Guizhou Herentang Pharmaceutical Co. Ltd.
Farmabios SpA
Lombardia, Italy
Vascular Imaging Corp.
Yissum Research Development Co. Ltd.
Israel
Deprenyl Animal Health, Inc.
Science Et Medecine
Advanced Systems Research, Inc.
Généthon
France
Prairie Pharms LLC
Iowa, United States
Southern College of Optometry
Certest Biotec SL
Login to view all
Hot Companies in Industries
Popular
Medicine
Biomedicine
Cancer
Biopharmaceutical
Biotechnology
Exosome
Biophysics
Shopify
Reddit
Tik tok
Apple
Squarespace
Soundcloud
Medium
Parallels
Zoom
Google
Godaddy
Microsoft
Forbes
Etsy
Huawei Technologies
Yandex
Amazon
Event brite
Dribbble
Hatena
Walmart
WPengine
Uber
Splunk
ServiceNow
Twilio
HubSpot
MuleSoft
Bloomberg
Cargill
E.I. du Pont de Nemours & Co.
EIDP, Inc.
F. Hoffmann-La Roche Ltd.
Toray Industries, Inc.
Olympus Medical Systems Corp.
The University of California, San Francisco
AstraZeneca UK Ltd.
Takeda Pharmaceutical Co., Ltd.
Genentech, Inc.
Covidien LP
Shanghai Jiao Tong University
Becton, Dickinson & Co. Ltd.
Bayer HealthCare Pharmaceuticals, Inc.
Bristol Myers Squibb Co.
Medtronic, Inc.
Huazhong University of Science & Technology
Ajinomoto Co., Inc.
Sanofi A/S
Novo Nordisk A/S
Sanofi-Aventis Deutschland GmbH
Boehringer Ingelheim Pharmaceuticals, Inc.
Amgen, Inc.
Wuhan University
Baxter International, Inc.
Nissan Chemical Corp.
Tongji University
The Johns Hopkins University
Alcon AG
Otsuka Pharmaceutical Co., Ltd.
University of Tokyo
Genentech, Inc.
Janssen Pharmaceutica NV
CJ CheilJedang Corp.
Japan Tobacco, Inc.
The Johns Hopkins University
Chugai Pharmaceutical Co., Ltd.
Les Laboratoires Servier SAS
Shionogi & Co., Ltd.
Yeda Research & Development Co. Ltd.
Grünenthal GmbH
Sumitomo Pharma Co., Ltd.
Dana-Farber Cancer Institute, Inc.
Duke University
Yissum Research Development Co. Ltd.
Ionis Pharmaceuticals, Inc.
Purdue Research Foundation
Taisho Pharmaceutical Co., Ltd.
The Brigham & Women's Hospital, Inc.
Yale University
National University of Singapore
Agency for Science, Technology & Research
Ono Pharmaceutical Co., Ltd.
CHIESI Farmaceutici SpA
National Research Council of Canada
Emory University
New York University
Washington University in St. Louis
Immatics Biotechnologies GmbH
CJ Corp.
Penn State Research Foundation
F. Hoffmann-La Roche Ltd.
Nippon Kayaku Co., Ltd.
Wisconsin Alumni Research Foundation
Clarient, Inc.
SyntheX, Inc.
Immatics Biotechnologies GmbH
Exelixis, Inc.
Corixa Corp.
Rigel Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc.
Medarex, Inc.
Pharmacyclics LLC
Elekta AB
Medivir AB
ChemoCentryx, Inc.
MacroGenics, Inc.
National Health Research Institutes
Juno Therapeutics, Inc.
Biovitrum AB
Kanazawa University
Epigenomics AG
Kagoshima University
Gunma University
H. Lee Moffitt Cancer Center & Research Institute, Inc.
Synta Pharmaceuticals Corp.
Xinxiang Medical University
Sorrento Therapeutics, Inc.
Curis, Inc.
Tottori University
Nanjing Medical University
F. Hoffmann-La Roche Ltd.
Takeda Pharmaceutical Co., Ltd.
Genentech, Inc.
Bristol Myers Squibb Co.
Novo Nordisk A/S
Amgen, Inc.
Commonwealth Scientific & Industrial Research Organisation
Regeneron Pharmaceuticals, Inc.
Chugai Pharmaceutical Co., Ltd.
Les Laboratoires Servier SAS
Vertex Pharmaceuticals, Inc.
California Institute of Technology
Gilead Sciences, Inc.
Yeda Research & Development Co. Ltd.
Kyoto University
Duke University
Yissum Research Development Co. Ltd.
Taisho Pharmaceutical Co., Ltd.
The Brigham & Women's Hospital, Inc.
Millennium Pharmaceuticals, Inc.
University of British Columbia
Fourth Military Medical University
Fourth Military Medical University
C.H. Boehringer Sohn AG & Co. KG
Human Genome Sciences, Inc.
UCB SA
Immatics Biotechnologies GmbH
Taiho Pharmaceutical Co., Ltd.
Yakult Honsha Co., Ltd.
Array BioPharma, Inc.
Genentech, Inc.
Monsanto Co.
Massachusetts Institute of Technology
Boehringer Ingelheim Pharmaceuticals, Inc.
CJ CheilJedang Corp.
Regeneron Pharmaceuticals, Inc.
The Johns Hopkins University
Chugai Pharmaceutical Co., Ltd.
Les Laboratoires Servier SAS
Shionogi & Co., Ltd.
Research Institute of Industrial Science & Technology
Yeda Research & Development Co. Ltd.
Kansai Paint Co., Ltd.
Sichuan Agricultural University
Grünenthal GmbH
JEOL Ltd.
Sumitomo Pharma Co., Ltd.
Genzyme Corp.
Dana-Farber Cancer Institute, Inc.
Incyte Corp.
Yissum Research Development Co. Ltd.
Ionis Pharmaceuticals, Inc.
University of Minnesota
Purdue Research Foundation
Life Technologies Corp.
Syngenta Ltd.
Taisho Pharmaceutical Co., Ltd.
Biogen MA, Inc.
The Brigham & Women's Hospital, Inc.
Yale University
Janssen Pharmaceutica NV
Les Laboratoires Servier SAS
Duke University
Yissum Research Development Co. Ltd.
The Brigham & Women's Hospital, Inc.
Agency for Science, Technology & Research
Clarient, Inc.
Emory University
CJ Corp.
Array BioPharma, Inc.
Case Western Reserve University
CJ Corp.
Idorsia Ltd.
Shanghai Institute of Materia Medica Chinese Academy of Sciences
Cedars-Sinai Medical Center
The Broad Institute, Inc.
QIAGEN GmbH
Boston University
Ventana Medical Systems, Inc.
King Abdullah University of Science & Technology
Louisiana State University
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Hangzhou Normal University
Kobe University
Acceleron Pharma, Inc.
Kaken Pharmaceutical Co., Ltd.
Medivir AB
National Health Research Institutes
Cytokinetics, Inc.
Epizyme, Inc.
Janssen Pharmaceutica NV
Les Laboratoires Servier SAS
Yeda Research & Development Co. Ltd.
Yissum Research Development Co. Ltd.
National University of Singapore
Agency for Science, Technology & Research
New York University
Technion Research & Development Foundation Ltd.
Technion Research & Development Foundation Ltd.
Ramot at Tel Aviv University Ltd.
The Rockefeller University
The Israel Institute for Biological Research
Georgetown University
Government of Australia
Kobe University
Nihon Medi-Physics Co., Ltd.
Kaken Pharmaceutical Co., Ltd.
Medivir AB
The Hong Kong Polytechnic University
University of Copenhagen
AiCuris GmbH & Co. KG
Auburn University
The Walter & Eliza Hall Institute of Medical Research
Southern Research Institute
AC Immune SA
Agensys, Inc.
Cilag AG
Amyris, Inc.
Bruker BioSpin Corp.
New York Blood Center, Inc.
View more
People also Viewed
ICC Technologies
Tianjin Aolian Special Steel Structure Installation Engineering patents
Toray Construction
Shenzhen Aoxingtai Technology patents
Kunshan Jinghe Mechanical and Electrical Engineering
Shanghai Lebai Robot
Economic and Technological Research Institute of State Grid Jiangsu Electric Power company profile
Alliance Elevator competitors
XMI company profile
Hangzhou Qinghuashe Chemical Industry
Fagui Technology
Ixchelsis competitors
Anhui Dongfangxu Electric Equipment patents
Longyan Honghang Sanitary Ware
Carbon Energy
Kunshan REN Precision Manufacturing competitors
Zhejiang Shouhang Industrial company profile
Shandong Shuocheng Machinery
Yantai Jereh Petroleum Equipment Technology patents
Tieling Flotation Reagents Factory patents
Laporte Industries patents
Consorcio G Grupo Dina de CV patents
Aditya Engineering College competitors
Hangzhou Aimei Aviation Manufacturing Equipment company profile
APC Products company profile
Hisense Home Appliances Group
Yichang Yuanlong Technology
Jiangsu Yongsheng Fluoroplastic New Material patents
Qinghai University competitors
Danyang Danjin Aviation Material Technology
Free Competitive Analysis!
Get Access
Sign up to get free competitive intelligence for millions of companies!
Page generation time: Oct 08 2022